The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Yes
Just like all the RNSs say just everyone on here trying to over complicate everything!
Capacity for this test, we could well have higher capacity for manufacturing another test (Avacta), I expect another RNS this week saying manufacturing deal with Avacta like Abington/BBI on instruction from Government.
Your missing the point if the RTC antibody test was going to be rolled out in huge volumes the government would have bought everything they could produce like Trump/abbot test. The fact the RTC companies are still outsourcing is a big clue!
We are mainly a manufacturer and will do very well these next few months. If the government had huge plans for the RTC tests they wouldn’t have wanted (allowed) BBI & Abingdon Health to move manufacturing capacity over to Avacta. I assume we will be next as clearly the government are wanting large quantities of their test. Getting a large contract from Avacta would be fantastic for Omega don’t understand where all the hostility between the boards come from.
Both will do well I suspect Omega will be the next manufacturer from the RTC consortium to announce manufacturing deal with Avacta. I hold both win/win
Sounds like Avacta, two of RTC already signed up (assuming with government nod) to produce their tests. If this was our antibody test needing 10million the RTC wouldn’t be giving manufacturing capacity away.
Government consortium, Avacta in Condor government programme join the dots
Just bought into this stock as it is one of Myles McNulty (if you haven’t heard of him look him up on twitter) two conviction buy stocks (Avacta the other). This guy is an investment god look back at his post buys/sells and follow the share prices. I will be loading up here at every opportunity
I think it’s clear that Premier Miton are drip feeding their remaining stock which is curtailing any rise at the moment. With all the recent positive news once they are out this will re rate big time and quickly in my opinion.
Sure Avacta could use our full capacity when their test comes to market would be my dream scenario as are my two biggest holdings.
I’m sure we will rise on the design freeze but we are basically a manufacturer, whether that is our own test or others players tests its orders which will increase the share price most. Other shares like Avacta will get royalty payments for their IP but we should hope there antigen test works as we could potentially pick up a HUGE manufacturing order from them. Many on this board seem to think Avacta are rivals which is not the case at all they could potentially make us millions in a manufacturing partnership. Orders from any firm is what it is all about for ODX the more tests that meet/pass licensing the better for us.
We could be the manufactures of there test that would be a double win for me as gold both!
Apart from the LFT RNS (hopefully) the RNS I would like to see most is Conifer increase in holdings. did they only want £10m? That is small fry to them, an increase in holdings RNS would in my opinion really rally the share price.
Does anyone really expect the deserter to actually happen? I expect Stem to be sold and all this is just a marketing exercise to flush out a buyer and a ploy to stop a cheap takeover of the whole company.
Think how many high net worth punters follow Greg Alexander also and will now buy Avacta on the back of his investment. Still don’t think this is our strategic investor though I predict further TR1 tomorrow morning with linked RNS with some joint developments.